The specific inhibitor of Cdc42, CASIN, decreased the oncogenicity of four Cdc42-overexpressing colorectal cancer cell lines (LIM1863, Caco2, LIM1899, and LIM2551) in vitro [9]. The gene discussed is CDC42; the disease is colorectal cancer.